136 related articles for article (PubMed ID: 109613)
1. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
[TBL] [Abstract][Full Text] [Related]
2. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids.
Wade JJ; Erickson EH; Hegel RF; Lappi LR; Rice TK
J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
[TBL] [Abstract][Full Text] [Related]
4. Structure--activity relationships in a series of novel 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylic acid antiallergy agents.
Althuis TH; Kadin SB; Czuba LJ; Moore PF; Hess HJ
J Med Chem; 1980 Mar; 23(3):262-9. PubMed ID: 6767846
[TBL] [Abstract][Full Text] [Related]
5. Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.
Althuis TH; Moore PF; Hess HJ
J Med Chem; 1979 Jan; 22(1):44-8. PubMed ID: 106118
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acids. 1.
Erickson EH; Lappi LR; Rice TK; Swingle KF; Van Winkle M
J Med Chem; 1978 Sep; 21(9):984-8. PubMed ID: 722763
[TBL] [Abstract][Full Text] [Related]
7. Antiallergic and cytoprotective activity of new N-phenylbenzamido acid derivatives.
Makovec F; Peris W; Revel L; Giovanetti R; Redaelli D; Rovati LC
J Med Chem; 1992 Oct; 35(20):3633-40. PubMed ID: 1433173
[TBL] [Abstract][Full Text] [Related]
8. Quinoline derivatives as antiallergy agents. 2. Fused-ring quinaldic acids.
Hall CM; Wright JB; Johnson HG; Taylor AJ
J Med Chem; 1977 Oct; 20(10):1337-43. PubMed ID: 903921
[TBL] [Abstract][Full Text] [Related]
9. The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG.
Riley PA; Sheard P; Clarke AJ; Orr TS
Life Sci; 1975 Sep; 17(5):793-802. PubMed ID: 813078
[No Abstract] [Full Text] [Related]
10. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
Spicer BA; Ross JW; Smith H
Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
[TBL] [Abstract][Full Text] [Related]
11. Studies on antianaphylactic agents. 5. Synthesis of 3-(1H-tetrazol-5-yl)chromones, a new series of antiallergic substances.
Nohara A; Kuriki H; Saijo T; Sugihara H; Kanno M; Sanno Y
J Med Chem; 1977 Jan; 20(1):141-5. PubMed ID: 13214
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of homologous passive cutaneous anaphylaxis (PCA) by disodium cromoglycate-related compounds.
Koda A; Sakamoto K; Yanagihara Y
Jpn J Pharmacol; 1980 Aug; 30(4):437-47. PubMed ID: 6162986
[TBL] [Abstract][Full Text] [Related]
13. New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma.
Cairns H; Cox D; Gould KJ; Ingall AH; Suschitzky JL
J Med Chem; 1985 Dec; 28(12):1832-42. PubMed ID: 2999403
[TBL] [Abstract][Full Text] [Related]
14. Studies on antianaphylactic agents. 6. Synthesis of some metabolites of 6-ethyl-3-(1H-tetrazol-5-yl)chromone and their analogues.
Nohara A; Kuriki H; Ishiguro T; Saijo T; Ukawa K; Maki Y; Sanno Y
J Med Chem; 1979 Mar; 22(3):290-5. PubMed ID: 423211
[TBL] [Abstract][Full Text] [Related]
15. Antiallergic agents. 2. N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides.
Honma Y; Oda K; Hashiyama T; Hanamoto K; Nakai H; Inoue H; Ishida A; Takeda M; Ono Y; Tsuzurahara K
J Med Chem; 1983 Oct; 26(10):1499-504. PubMed ID: 6137568
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides.
Ford RE; Knowles P; Lunt E; Marshall SM; Penrose AJ; Ramsden CA; Summers AJ; Walker JL; Wright DE
J Med Chem; 1986 Apr; 29(4):538-49. PubMed ID: 2870188
[TBL] [Abstract][Full Text] [Related]
17. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
Hashimoto T; Edanami K; Naito A; Sano K; Fushimi H; Goto M
Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiallergy activity of 4-oxopyrano[3,2-b]indoles.
Unangst PC; Brown RE; Herzig DJ
J Med Chem; 1980 Nov; 23(11):1251-5. PubMed ID: 7452677
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P
J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518
[TBL] [Abstract][Full Text] [Related]
20. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat.
Riley PA; Mather ME; Keogh RW; Eady RP
Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
